tirzepatide naion risk Semaglutide use in patients with diabetes was associated with an increased of nonarteritic anterior ischemic optic neuropathy (NAION) at 2, 3, and 4 years. https://ja.ma/4iZkMeV Risk of nonarteritic anterior ischemic

The relationship between Ozempic and breathlessness is not straightforward

however, post-mortem interval was negatively associated with GSSG in the combined case/control cohort of samples from BA22 ( r =0.57

A reappraisal of the histologic findings of pigmented pretibial patches of diabetes mellitus

Sustainable Weight Loss: Clinical trials have shown that patients using Semaglutide can achieve a 15 to 20% loss in body weight compared to an average 2.4% weight loss with traditional methods

Generally, benefits can last about one to three months

Beyond the anticipated benefits for pulmonary health, there is interest in whether GLP-1RAs may improve specific lung diseases